What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
His primary scientific interests are in Immunology, Molecular biology, Internal medicine, Cell biology and Pathology.
His research in Atopic dermatitis, CC chemokine receptors, Immunoglobulin E, Chemokine and Antibody are components of Immunology.
His Molecular biology research includes themes of Cytokine, Type I collagen, Receptor, Matrix metalloproteinase and Kinase.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology and Surgery.
His Cell biology research is multidisciplinary, incorporating perspectives in Biochemistry and Antigen.
Kunihiko Tamaki works in the field of Pathology, focusing on Fibrosis in particular.
His most cited work include:
- Epidermal Langerhans cells are derived from cells originating in bone marrow. (788 citations)
- Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. (439 citations)
- Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis–like lesions (365 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Immunology, Pathology, Molecular biology, Internal medicine and Dermatology.
His study in Antibody, Atopic dermatitis, Chemokine, Immunoglobulin E and CCL17 falls under the purview of Immunology.
His research on Pathology often connects related areas such as Antigen.
His Molecular biology study incorporates themes from Gene expression, Receptor, Signal transduction, Transforming growth factor and Epidermis.
His Internal medicine course of study focuses on Endocrinology and Fibroblast.
Kunihiko Tamaki works mostly in the field of Connective tissue disease, limiting it down to concerns involving Immunopathology and, occasionally, Autoimmune disease.
He most often published in these fields:
- Immunology (31.42%)
- Pathology (28.19%)
- Molecular biology (16.52%)
What were the highlights of his more recent work (between 2006-2016)?
- Pathology (28.19%)
- Immunology (31.42%)
- Dermatology (15.80%)
In recent papers he was focusing on the following fields of study:
Kunihiko Tamaki spends much of his time researching Pathology, Immunology, Dermatology, Internal medicine and Cell biology.
As a part of the same scientific study, Kunihiko Tamaki usually deals with the Pathology, concentrating on Epidermis and frequently concerns with Proinflammatory cytokine.
His Dermatology study combines topics in areas such as After treatment and Prednisolone.
His work deals with themes such as Gastroenterology, Endocrinology and Immune system, which intersect with Internal medicine.
As part of the same scientific family, Kunihiko Tamaki usually focuses on Cell biology, concentrating on CD19 and intersecting with Regulatory B cells.
His Regulatory B cells research focuses on Molecular biology and how it relates to Cell culture.
Between 2006 and 2016, his most popular works were:
- Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. (233 citations)
- A randomized double-blind trial of intravenous immunoglobulin for pemphigus (158 citations)
- Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. (109 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Kunihiko Tamaki mainly focuses on Immunology, Pathology, Internal medicine, Atopic dermatitis and Chemokine.
Kunihiko Tamaki interconnects Involucrin, Etretinate and Cell biology in the investigation of issues within Pathology.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Endocrinology.
His Atopic dermatitis study integrates concerns from other disciplines, such as Young adult, Allergy, MEDLINE and CCL27.
His Chemokine research incorporates themes from Chemotaxis, Cytokine and CD40.
His research integrates issues of CD1D, Molecular biology, Adoptive cell transfer, CD19 and CD5 in his study of Regulatory B cells.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
